The aggressive properties of cancer stem cells are being fueled by a subset of immune cells directly targeting colon cancers rather than the immune system.
So finds a new study that is an international collaboration among researchers from the United States, China and Poland.
Aspirin Could Help Tackle Colon Cancer in Individuals Having a Specific Gene
People carrying high levels of a specific type of gene have a chance of reducing the risk of colon cancer by half with the intake of aspirin as per study released on Wednesday.
Advertisement
"If you want to control cancer stem cells through new therapies, then you need to understand what controls the cancer stem cells," says senior study author Weiping Zou, M.D., Ph.D., Charles B. de Nancrede Professor of surgery, immunology and biology at the University of Michigan Medical School.
Consider invasive Africanized honey bees. The worker honey bees are like the bulk majority of tumor cells while the queen bee is like the cancer stem cell. The queen bee can repopulate an entire colony but survives on royal jelly. If you remove the royal jelly, the queen bee dies and the entire colony of invasive Africanized honey bees can be removed. Th22-derived IL-22 is the royal jelly.
![Key Steps Linking Dietary Fats and Colon Cancer Tumor Growth Found by Scientists]( "Key Steps Linking Dietary Fats and Colon Cancer Tumor Growth Found by Scientists")
A new genetic evidence was shown by scientists that could strengthen the link between the role of dietary fats with colon cancer progression.
Th22 is a subset of a type of immune cell called T-cells. Typically, T-cells are the soldiers of the immune system, killing off tumor cells. In the case of colon cancer, the researchers found, Th22 acts as a tumor helper, actually supporting the cells in becoming able to renew - one of the hallmarks of cancer stem cells.
The researchers discovered that an epigenetic factor called DOT1L is regulated by IL-22, contributing to the cells developing stem cell properties. High levels of DOT1L in patient tumor samples were tied to shorter survival. The researchers suggest DOT1L may be a marker for colon cancer progression, and that this pathway could potentially be targeted in new colon cancer treatments.
The researchers are now looking at potential drugs that might target this process directly. No specific therapies are currently available.
Tumor immunology and immunotherapy has become a hot research topic recently. Science named it the breakthrough of the year in 2013. Zou''s group has been among the pioneers in understanding how the immune system plays a role in cancer.
The study was led by Ilona Kryczek, Yanwei Lin and Nisha Nagarsheth. Results appear online in the journal Immunity.
Source: Newswise
Key Steps Linking Dietary Fats and Colon Cancer Tumor Growth Found by Scientists
A new genetic evidence was shown by scientists that could strengthen the link between the role of dietary fats with colon cancer progression.
Advertisement
Th22 is a subset of a type of immune cell called T-cells. Typically, T-cells are the soldiers of the immune system, killing off tumor cells. In the case of colon cancer, the researchers found, Th22 acts as a tumor helper, actually supporting the cells in becoming able to renew - one of the hallmarks of cancer stem cells.
The researchers discovered that an epigenetic factor called DOT1L is regulated by IL-22, contributing to the cells developing stem cell properties. High levels of DOT1L in patient tumor samples were tied to shorter survival. The researchers suggest DOT1L may be a marker for colon cancer progression, and that this pathway could potentially be targeted in new colon cancer treatments.
The researchers are now looking at potential drugs that might target this process directly. No specific therapies are currently available.
Tumor immunology and immunotherapy has become a hot research topic recently. Science named it the breakthrough of the year in 2013. Zou''s group has been among the pioneers in understanding how the immune system plays a role in cancer.
The study was led by Ilona Kryczek, Yanwei Lin and Nisha Nagarsheth. Results appear online in the journal Immunity.
Source: Newswise
Web Information on Colon Cancer too Complex, Do Not Address Key Concerns
Popular web information on colorectal cancer is too difficult for most lay people to read and doesn't address the appropriate risks to and concerns of patients.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Research News
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.